Review
doi: 10.1007/978-0-387-33012-9_85.Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization
Affiliations
- PMID:17037581
- PMCID: PMC7123641
- DOI: 10.1007/978-0-387-33012-9_85
Item in Clipboard
Review
Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization
Hong Peng Jia et al. Adv Exp Med Biol.2006.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Insights from the association of SARS-CoV S-protein with its receptor, ACE2.Li W, Choe H, Farzan M.Li W, et al.Adv Exp Med Biol. 2006;581:209-18. doi: 10.1007/978-0-387-33012-9_36.Adv Exp Med Biol. 2006.PMID:17037532Free PMC article.Review.No abstract available.
- Cellular entry of the SARS coronavirus.Hofmann H, Pöhlmann S.Hofmann H, et al.Trends Microbiol. 2004 Oct;12(10):466-72. doi: 10.1016/j.tim.2004.08.008.Trends Microbiol. 2004.PMID:15381196Free PMC article.Review.
- ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr.Jia HP, et al.J Virol. 2005 Dec;79(23):14614-21. doi: 10.1128/JVI.79.23.14614-14621.2005.J Virol. 2005.PMID:16282461Free PMC article.
- Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, Muench MO, Simmons G, Hofmann H, Kuri T, Weber F, Eichler J, Drosten C, Pöhlmann S.Glowacka I, et al.J Virol. 2010 Jan;84(2):1198-205. doi: 10.1128/JVI.01248-09. Epub 2009 Oct 28.J Virol. 2010.PMID:19864379Free PMC article.
- Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.Kuhn JH, Li W, Radoshitzky SR, Choe H, Farzan M.Kuhn JH, et al.Antivir Ther. 2007;12(4 Pt B):639-50.Antivir Ther. 2007.PMID:17944271Review.
Cited by
- Current emerging SARS-CoV-2 pandemic: Potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments.Race M, Ferraro A, Galdiero E, Guida M, Núñez-Delgado A, Pirozzi F, Siciliano A, Fabbricino M.Race M, et al.Environ Res. 2020 Sep;188:109808. doi: 10.1016/j.envres.2020.109808. Epub 2020 Jun 10.Environ Res. 2020.PMID:32544725Free PMC article.
- Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.Trandafir LM, Spoiala EL, Ghiga G, Gimiga N, Budescu PD, Lupu VV, Butnariu L, Cojocaru E, Paduraru G.Trandafir LM, et al.J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.J Pers Med. 2024.PMID:38673026Free PMC article.Review.
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.Jia HP, Look DC, Tan P, Shi L, Hickey M, Gakhar L, Chappell MC, Wohlford-Lenane C, McCray PB Jr.Jia HP, et al.Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L84-96. doi: 10.1152/ajplung.00071.2009. Epub 2009 May 1.Am J Physiol Lung Cell Mol Physiol. 2009.PMID:19411314Free PMC article.
- Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.Rando HM, MacLean AL, Lee AJ, Lordan R, Ray S, Bansal V, Skelly AN, Sell E, Dziak JJ, Shinholster L, McGowan LD, Guebila MB, Wellhausen N, Knyazev S, Boca SM, Capone S, Qi Y, Park Y, Sun Y, Mai D, Boerckel JD, Brueffer C, Byrd JB, Kamil JP, Wang J, Velazquez R, Szeto GL, Barton JP, Goel RR, Mangul S, Lubiana T; COVID-19 Review Consortium; Gitter A, Greene CS.Rando HM, et al.ArXiv [Preprint]. 2021 Feb 1:arXiv:2102.01521v4.ArXiv. 2021.Update in:mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21.PMID:33594340Free PMC article.Updated.Preprint.
- Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD.Osan JK, Talukdar SN, Feldmann F, DeMontigny BA, Jerome K, Bailey KL, Feldmann H, Mehedi M.Osan JK, et al.bioRxiv [Preprint]. 2020 Nov 12:2020.11.11.379099. doi: 10.1101/2020.11.11.379099.bioRxiv. 2020.Update in:Microbiol Spectr. 2022 Aug 31;10(4):e0045922. doi: 10.1128/spectrum.00459-22.PMID:33200131Free PMC article.Updated.Preprint.
References
- Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson RM. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761–1766. doi: 10.1016/S0140-6736(03)13410-1. - DOI - PMC - PubMed
- Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 2003;348:1995–2005. doi: 10.1056/NEJMoa030634. - DOI - PubMed
- Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, McEvoy CP, Hayden CD, Fukuoka J, Taubenberger JK, Travis WD. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 2003;34:743–748. doi: 10.1016/S0046-8177(03)00367-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous